Autres langues TransMedics Group, Inc.

Actions

TMDX

US89377M1099

Temps réel estimé Cboe BZX Autres places de cotation 20:42:23 02/05/2024			Varia. 5j.	Varia. 1 janv.
122,6 ^USD	+4,28%		+37,68%	+55,68%

01/05	Les actions de TransMedics Group augmentent alors que le T1 passe au bénéfice net, que les revenus augmentent et que les perspectives de revenus pour 2024 sont revues à la hausse	MT
01/05	TRANSMEDICS GROUP, INC. : Oppenheimer favorable sur le dossier	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

TransMedics Group Shares Rise as Q1 Swings to Net Income, Revenue Rises; Increases 2024 Revenue Outlook	01/05
Earnings Flash (TMDX) TRANSMEDICS GROUP Posts Q1 Revenue $96.9M, vs. Street Est of $83.8M	30/04
TransMedics Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
TransMedics: Q1 Earnings Snapshot	30/04
TransMedics Reports First Quarter 2024 Financial Results	30/04
TransMedics Group, Inc. Raises Revenue Guidance for the Full Year 2024	30/04
Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing	18/04
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024	16/04
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	08/04
Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing	05/04
Transmedics Group Insider Sold Shares Worth $1,110,150, According to a Recent SEC Filing	02/04
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	19/03
TMDX INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX	03/03
TransMedics to Present at Upcoming March Investor Conferences	28/02
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	28/02
Top Premarket Gainers	27/02
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX	27/02
TransMedics: Q4 Earnings Snapshot	26/02
TransMedics Group Swings to Net Income in Q4, Revenue Increases; Sets 2024 Revenue Outlook-- Shares Rise	26/02
TransMedics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues TransMedics Group, Inc.

Actions

TMDX

US89377M1099

Autres langues

Filtres